Novartis (NYSE: NVS) Upgrades Profit Outlook for Second Time
FRANKFURT – Swiss drugmaker Novartis (NYSE: NVS) raised its 2024 earnings guidance for the second time on Thursday, driven by […]
Novartis (NYSE: NVS) Upgrades Profit Outlook for Second Time Read More »
